{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:15:09Z","timestamp":1784862909117,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation of China","doi-asserted-by":"crossref","award":["2023JJ30060"],"award-info":[{"award-number":["2023JJ30060"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Changsha Science and Technology Bureau Scientifc Research Projec","award":["Kq2004155"],"award-info":[{"award-number":["Kq2004155"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00284-023-03332-x","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T13:02:26Z","timestamp":1685538146000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Repurposing CD5789 as an Antimicrobial Agent Against MRSA and Its High Resistant Phonotypes"],"prefix":"10.1007","volume":"80","author":[{"given":"Zhengli","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuoxun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengshu","family":"Que","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"key":"3332_CR1","doi-asserted-by":"publisher","first-page":"e00020","DOI":"10.1128\/CMR.00020-18","volume":"31","author":"S Lakhundi","year":"2018","unstructured":"Lakhundi S, Zhang K (2018) Methicillin-resistant Staphylococcus aureus: molecular characterization, evolution, and epidemiology. Clin Microbiol Rev 31:e00020-e118","journal-title":"Clin Microbiol Rev"},{"key":"3332_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/microorganisms11010024","volume":"11","author":"G Li","year":"2022","unstructured":"Li G, Walker MJ, De Oliveira DMP (2022) Vancomycin resistance in Enterococcus and Staphylococcus aureus. Microorganisms 11:24","journal-title":"Microorganisms"},{"key":"3332_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3390\/antibiotics12010087","volume":"12","author":"FF Tuon","year":"2023","unstructured":"Tuon FF, Suss PH, Telles JP et al (2023) Antimicrobial treatment of Staphylococcus aureus biofilms. Antibiotics (Basel) 12:87","journal-title":"Antibiotics (Basel)"},{"key":"3332_CR4","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ijantimicag.2009.12.011","volume":"35","author":"N Hoiby","year":"2010","unstructured":"Hoiby N, Bjarnsholt T, Givskov M et al (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35:322\u2013332","journal-title":"Int J Antimicrob Agents"},{"key":"3332_CR5","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s12272-020-01246-x","volume":"43","author":"J Chang","year":"2020","unstructured":"Chang J, Lee RE, Lee W (2020) A pursuit of Staphylococcus aureus continues: a role of persister cells. Arch Pharm Res 43:630\u2013638","journal-title":"Arch Pharm Res"},{"key":"3332_CR6","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12866-017-1129-9","volume":"17","author":"GS Sahukhal","year":"2017","unstructured":"Sahukhal GS, Pandey S, Elasri MO (2017) msaABCR operon is involved in persister cell formation in Staphylococcus aureus. BMC Microbiol 17:218","journal-title":"BMC Microbiol"},{"key":"3332_CR7","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2217\/fmb-2019-0122","volume":"14","author":"G Kaul","year":"2019","unstructured":"Kaul G, Shukla M, Dasgupta A et al (2019) Update on drug-repurposing: is it useful for tackling antimicrobial resistance? Future Microbiol 14:829\u2013831","journal-title":"Future Microbiol"},{"key":"3332_CR8","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.2174\/1381612821666150506154434","volume":"21","author":"W Younis","year":"2015","unstructured":"Younis W, Thangamani S, Seleem MN (2015) Repurposing non-antimicrobial drugs and clinical molecules to treat bacterial infections. Curr Pharm Des 21:4106\u20134111","journal-title":"Curr Pharm Des"},{"key":"3332_CR9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2213363120","volume":"120","author":"L Schwartz","year":"2023","unstructured":"Schwartz L, Bochter MS, Simoni A et al (2023) Repurposing HDAC inhibitors to enhance ribonuclease 4 and 7 expression and reduce urinary tract infection. Proc Natl Acad Sci U S A 120:e2213363120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3332_CR10","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s40265-019-01218-6","volume":"79","author":"LJ Scott","year":"2019","unstructured":"Scott LJ (2019) Trifarotene: first approval. Drugs 79:1905\u20131909","journal-title":"Drugs"},{"key":"3332_CR11","doi-asserted-by":"publisher","first-page":"1504303","DOI":"10.1155\/2022\/1504303","volume":"2022","author":"PP Naik","year":"2022","unstructured":"Naik PP (2022) Trifarotene: a novel therapeutic option for acne. Dermatol Res Pract 2022:1504303","journal-title":"Dermatol Res Pract"},{"key":"3332_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3390\/biomedicines9030237","volume":"9","author":"T Cosio","year":"2021","unstructured":"Cosio T, Di Prete M, Gaziano R et al (2021) Trifarotene: a current review and rerspectives in dermatology. Biomedicines 9:237","journal-title":"Biomedicines"},{"key":"3332_CR13","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2020) Performance standard for antimicrobial susceptibility testing; thirtieth informational supplement. CLSI Document (M100Ed30). Wayne."},{"key":"3332_CR14","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.3389\/fmicb.2019.02301","volume":"10","author":"F Tan","year":"2019","unstructured":"Tan F, She P, Zhou L et al (2019) Bactericidal and anti-biofilm activity of the retinoid compound CD437 against Enterococcus faecalis. Front Microbiol 10:2301","journal-title":"Front Microbiol"},{"key":"3332_CR15","doi-asserted-by":"publisher","first-page":"e00422","DOI":"10.1128\/mSphere.00422-18","volume":"3","author":"RP Trombetta","year":"2018","unstructured":"Trombetta RP, Dunman PM, Schwarz EM et al (2018) A high-throughput screening approach to repurpose FDA-approved drugs for bactericidal applications against Staphylococcus aureus small-colony variants. mSphere 3:e00422-e518","journal-title":"mSphere"},{"key":"3332_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/mbo3.338","volume":"5","author":"L Qu","year":"2016","unstructured":"Qu L, She P, Wang Y et al (2016) Effects of norspermidine on Pseudomonas aeruginosa biofilm formation and eradication. Microbiologyopen 5:402\u2013412","journal-title":"Microbiologyopen"},{"key":"3332_CR17","doi-asserted-by":"publisher","first-page":"16529","DOI":"10.1073\/pnas.1904700116","volume":"116","author":"W Kim","year":"2019","unstructured":"Kim W, Zou G, Hari TPA et al (2019) A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A 116:16529\u201316534","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3332_CR18","doi-asserted-by":"publisher","first-page":"1902227","DOI":"10.1002\/advs.201902227","volume":"7","author":"Y Liu","year":"2020","unstructured":"Liu Y, Jia Y, Yang K et al (2020) Metformin restores tetracyclines susceptibility against multidrug resistant bacteria. Adv Sci (Weinh) 7:1902227","journal-title":"Adv Sci (Weinh)"},{"key":"3332_CR19","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1007\/s00253-022-11878-2","volume":"106","author":"Y Li","year":"2022","unstructured":"Li Y, She P, Xu L et al (2022) Anti-hepatitis C virus drug simeprevir: a promising antimicrobial agent against MRSA. Appl Microbiol Biotechnol 106:2689\u20132702","journal-title":"Appl Microbiol Biotechnol"},{"key":"3332_CR20","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41586-022-05260-5","volume":"610","author":"V L\u00e1z\u00e1r","year":"2022","unstructured":"L\u00e1z\u00e1r V, Snitser O, Barkan D et al (2022) Antibiotic combinations reduce Staphylococcus aureus clearance. Nature 610:540\u2013546","journal-title":"Nature"},{"key":"3332_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.751909","volume":"12","author":"F Kato","year":"2021","unstructured":"Kato F, Nakatsu Y, Murano K et al (2021) Antiviral activity of CD437 against mumps virus. Front Microbiol 12:751909","journal-title":"Front Microbiol"},{"key":"3332_CR22","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.3390\/ijerph16183428","volume":"16","author":"SH Kwak","year":"2019","unstructured":"Kwak SH, Nam GS, Bae SH et al (2019) Effect of specific retinoic acid receptor agonists on noise-induced hearing loss. Int J Environ Res Public Health 16:3428","journal-title":"Int J Environ Res Public Health"},{"key":"3332_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature26157","volume":"556","author":"W Kim","year":"2018","unstructured":"Kim W, Zhu W, Hendricks GL et al (2018) A new class of synthetic retinoid antibiotics effective against bacterial persisters. Nature 556:103\u2013107","journal-title":"Nature"},{"key":"3332_CR24","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1080\/21505594.2020.1770493","volume":"11","author":"P She","year":"2020","unstructured":"She P, Li S, Zhou L et al (2020) Insights into idarubicin antimicrobial activity against methicillin-resistant Staphylococcus aureus. Virulence 11:636\u2013651","journal-title":"Virulence"},{"key":"3332_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/mbo3.1063","volume":"9","author":"L Chen","year":"2020","unstructured":"Chen L, Li H, Wen H et al (2020) Biofilm formation in Acinetobacter baumannii was inhibited by PA\u03b2N while it had no association with antibiotic resistance. Microbiologyopen 9:e1063","journal-title":"Microbiologyopen"},{"key":"3332_CR26","doi-asserted-by":"publisher","first-page":"eaan4044","DOI":"10.1126\/scitranslmed.aan4044","volume":"10","author":"A de Breij","year":"2018","unstructured":"de Breij A, Riool M, Cordfunke RA et al (2018) The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Sci Transl Med 10:eaan4044","journal-title":"Sci Transl Med"},{"key":"3332_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.727692","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, She P, Xu L et al (2021) Antimicrobial, antibiofilm, and anti-persister activities of penfluridol against Staphylococcus aureus. Front Microbiol 12:727692","journal-title":"Front Microbiol"},{"key":"3332_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/antibiotics12010012","volume":"12","author":"Q Peng","year":"2022","unstructured":"Peng Q, Tang X, Dong W et al (2022) A review of biofilm formation of Staphylococcus aureus and its regulation mechanism. Antibiotics (Basel) 12:12","journal-title":"Antibiotics (Basel)"},{"key":"3332_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/14787210.2020.1705155","volume":"18","author":"ARM Coates","year":"2020","unstructured":"Coates ARM, Hu Y, Holt J et al (2020) Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction. Expert Rev Anti Infect Ther 18:5\u201315","journal-title":"Expert Rev Anti Infect Ther"},{"key":"3332_CR30","doi-asserted-by":"publisher","first-page":"lxac023","DOI":"10.1093\/jambio\/lxac023","volume":"134","author":"Z Li","year":"2023","unstructured":"Li Z, She P, Liu Y et al (2023) Triple combination of SPR741, clarithromycin, and erythromycin against Acinetobacter baumannii and its tolerant phenotype. J Appl Microbiol 134:lxac023","journal-title":"J Appl Microbiol"},{"key":"3332_CR31","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2147\/TCRM.S286953","volume":"17","author":"CM Brumfiel","year":"2021","unstructured":"Brumfiel CM, Patel MH, Bell KA et al (2021) Assessing the safety and efficacy of trifarotene in the treatment of Acne vulgaris. Ther Clin Risk Manag 17:755\u2013763","journal-title":"Ther Clin Risk Manag"},{"key":"3332_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.idc.2020.10.003","volume":"35","author":"TJ Hatlen","year":"2021","unstructured":"Hatlen TJ, Miller LG (2021) Staphylococcal skin and soft tissue infections. Infect Dis Clin North Am 35:81\u2013105","journal-title":"Infect Dis Clin North Am"},{"key":"3332_CR33","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.jaad.2019.02.044","volume":"80","author":"J Tan","year":"2019","unstructured":"Tan J, Thiboutot D, Popp G et al (2019) Randomized phase 3 evaluation of trifarotene 50 \u03bcg\/g cream treatment of moderate facial and truncal acne. J Am Acad Dermatol 80:1691\u20131699","journal-title":"J Am Acad Dermatol"},{"key":"3332_CR34","doi-asserted-by":"publisher","first-page":"582","DOI":"10.36849\/JDD.6778","volume":"21","author":"L Eichenfield","year":"2022","unstructured":"Eichenfield L, Kwong P, Lee S et al (2022) Advances in topical management of adolescent facial and truncal acne: a phase 3 pooled analysis of safety and efficacy of trifarotene 0.005% cream. J Drugs Dermatol 21:582\u2013586","journal-title":"J Drugs Dermatol"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-023-03332-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-023-03332-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-023-03332-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T02:05:55Z","timestamp":1686708355000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-023-03332-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["3332"],"URL":"https:\/\/doi.org\/10.1007\/s00284-023-03332-x","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]},"assertion":[{"value":"21 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"230"}}